Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1beta in pigs in vivo
Autor: | Toshiaki Kadokami, Yoshikazu Yonemitsu, Yoshihiro Fukumoto, Kouichi Kuwata, Kensuke Egashira, Katsuo Sueishi, Toshiyuki Kozai, Hiroaki Shimokawa, Takeshi Kuga, Akira Takeshita |
---|---|
Rok vydání: | 1997 |
Předmět: |
Male
Pathology medicine.medical_specialty Vascular smooth muscle Swine Coronary Artery Disease Pharmacology Guanidines Muscle Smooth Vascular Proinflammatory cytokine Pathogenesis In vivo Enos Physiology (medical) medicine Animals biology business.industry Arteriosclerosis medicine.disease biology.organism_classification Coronary Vessels Immunohistochemistry Nitric oxide synthase NG-Nitroarginine Methyl Ester Vasoconstriction biology.protein Nitric Oxide Synthase Cardiology and Cardiovascular Medicine business Immunostaining Interleukin-1 |
Zdroj: | Circulation. 96(9) |
ISSN: | 0009-7322 |
Popis: | Background We recently developed a porcine model in which chronic, local treatment with interleukin-1β (IL-1β) causes coronary arteriosclerotic changes and hyperconstrictive responses. Inflammatory cytokines are known to induce inducible NO synthase (iNOS) in the vascular smooth muscle. This study was designed to examine whether or not the production of NO by iNOS has a protective or deleterious effect on the coronary artery in vivo. Methods and Results A segment of the porcine coronary artery was aseptically wrapped with cotton mesh absorbing IL-1β suspension. We inhibited both eNOS and iNOS activity by cotreatment with L-NAME (a nonspecific inhibitor of NOS) and iNOS activity alone by aminoguanidine (a selective inhibitor of iNOS). Immunostaining showed that iNOS was absent in the normal coronary artery, whereas it was highly expressed 1 day after the application of IL-1β and thereafter downregulated until 14 days. In contrast, eNOS was well maintained throughout the study period. Two weeks after the operation, hyperconstrictive responses to intracoronary serotonin and neointimal formation were noted at the IL-1β–treated site, and both responses were significantly greater at the site cotreated with either L-NAME or aminoguanidine. Conclusions These results indicate that iNOS is transiently induced in vivo in response to local inflammation and that NO produced by iNOS exerts an inhibitory effect against the cytokine-induced proliferative/vasospastic changes of the coronary artery in vivo. |
Databáze: | OpenAIRE |
Externí odkaz: |